Arymo ER FDA Approval History
FDA Approved: Yes (Discontinued) (First approved January 9, 2017)
Brand name: Arymo ER
Generic name: morphine sulfate
Dosage form: Extended-Release Tablets
Company: Egalet Corporation
Treatment for: Pain
Marketing Status: Discontinued
Arymo ER (morphine sulfate) is an extended-release, abuse-deterrent, opioid analgesic formulation for the management of severe pain.
Development timeline for Arymo ER
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.